Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical effects of dexamethasone among patients with sickle cell disease hospitalized with COVID-19: Outcomes from a single academic health system

PLoS ONE(2024)10.1371/journal.pone.0313289Source: DataRank Database

Clinical effects of dexamethasone among patients with sickle cell disease hospitalized with COVID-19: Outcomes from a single academic health system is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (69)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Matthew Lankiewicz,Catherine R. Lesko ORCID,Ashley Lauriello,Kelly A. Gebo ORCID,Sophie Lanzkron ORCID

Live enrichment

PubMed:39591463 PMC:PMC11594400 OpenAlex:https://openalex.org/W4404739171

National Center for Advancing Translational Sciences

Grant: KL2TR003099

Institute for Clinical and Translational Research

Grant: 1UL1TR001079-01

Institute for Clinical and Translational Research

NCATS NIH HHS

Grant: UL1 TR001079

National Institutes of Health

Grant: 5KL2TR003099-05

Institutional Career Development Core

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by

journalhttp://dx.doi.org/10.1371/journal.pone.0313289

publisherhttp://dx.doi.org/10.1371/journal.pone.0313289

publisherhttps://dx.plos.org/10.1371/journal.pone.0313289

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39591463

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11594400

Fields of Study

Hemoglobinopathies and Related DisordersCOVID-19 Clinical Research StudiesBlood groups and transfusion03 medical and health sciences0302 clinical medicineHumansDexamethasoneMaleFemaleAnemia, Sickle CellAdultRetrospective StudiesCOVID-19COVID-19 Drug TreatmentHospitalizationMiddle AgedSARS-CoV-2Length of StayIntensive Care UnitsVenous ThromboembolismTreatment Outcome

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAdultAnemia, Sickle CellDexamethasoneFemaleHospitalizationHumansIntensive Care UnitsLength of StayMaleMiddle AgedRetrospective StudiesTreatment OutcomeVenous Thromboembolism

Keywords

DexamethasoneMedicineRetrospective cohort studyInternal medicinePopulationCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)MaleAdultintensive care unitsSciencevenous thromboembolism610Anemia, Sickle Cellsickle celllength of staymiddle aged616HumansRetrospective StudiesSARS-CoV-2QRCOVID-19 drug treatmentCOVID-19HematologyanemiaHospitalizationfemaleTreatment OutcomeResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being